The DAINA 2 competition, organised by NCN in cooperation with the Lithuanian Scientific Council, was addressed to Polish research teams, which jointly with the Lithuanian team applied for the financing of a research project. The project entitled 'Regulation of the p53 pathway by the AAA+ family protein (Reptin)' under the leadership of prof. Theodore Robert Hupp from the International Centre for Cancer Vaccine Research of the University of Gdansk and prof. Daumantas Matulis from Vilnius University was qualified for funding.
In response to the announcement of the DAINA 2 competition, the organiser received 133 applications for a total amount of over PLN 113 million.
The competition was open to proposals covering research carried out under three main headings: HS - humanities, social and art sciences; ST - sciences and technology; NZ - life sciences. The largest number of applications was submitted in the science and technology panels - 56, in the humanities, social sciences and arts - 41 applications, and in life sciences - 36. 11 research projects were qualified for funding, for a total amount of PLN 11,691,311.
Laureates from the humanities, social sciences and arts will examine, among other things, mobility, migration and the COVID-19 epidemic from the perspective of emergency management in Lithuania and Poland. Representatives from the life sciences will look at, among other things, the manipulation of drug resistance in cancer cells through nanosecond asymmetric pulse sequences. Science and technology projects on the ranking list include research into the importance of long-range transport of biomass burning emissions for local smog in urban environments.
In the NZ panel, the project 'Regulation of the p53 pathway by the AAA+ family protein (Reptin)' led by prof. Theodore Robert Hupp from the International Centre for Cancer Vaccine Research UG and prof. Daumantas Matulis from Vilnius University qualified for funding.
- 'Our interdisciplinary team of researchers from Vilnius and Gdansk is a part of a new trend in scientific research about translational drug discovery, which brings together researchers with different specialities. The research aims to develop new strategies for testing anti-cancer therapies. We propose to use synthetic amino acids, not found in nature, to develop synthetic proteins used in the discovery of new compounds with therapeutic potential. The project is an opportunity for a new generation of scientists from Lithuania and Poland to apply innovative methods of synthetic biology in medical research,' says prof. Theodor Robert Hupp from the International Centre for Cancer Vaccine Research at the University of Gdansk.
More information about the competition: NCN